Ligand Reports Fourth Quarter and Full Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. OKTA
3. ORCL
4. SPY
5. P
6. MCD
7. MGM
8. NVDA
9. ACAD
10. GDDY

Go back to Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
LIGAND PHARMA (NASDAQ: LGND) Delayed: 300.51 +2.10 (0.70%)
Previous Close $298.41    52 Week High $139.79 
Open $296.95    52 Week Low $82.07 
Day High $301.39    P/E 698.86 
Day Low $296.37    EPS $0.43 
Volume 64,131       

(NASDAQ: VRNA) Delayed: 106.91 --0 (-0%)
Previous Close $106.91    52 Week High $ 
Open $106.91    52 Week Low $ 
Day High $106.91    P/E N/A 
Day Low $106.91    EPS $ 
Volume 687,612